Sachseln, Switzerland-based Maxon disclosed annual revenue growth of 13% to CHF 707.7 million (roughly $815 million in U.S. currency) and a 4% increase in global headcount of 3,341 employees.
The medtech market was an “important pillar” despite market saturation for ventilators after rapid growth due to the COVID-19 pandemic, the company said in a news release. Increased semiconductor deliveries compensated for that in a market “driven by shortages in the supply of electronic components.”
Related: 5 steps to help medical device makers deal with semiconductor shortages
…